Sonoma Pharmaceuticals' Microcyn hydrogel gets FDA clearance for wound care, available OTC for minor skin issues.

Sonoma Pharmaceuticals has received FDA 510(k) clearance for its Microcyn technology-based hydrogel, which can be used by healthcare professionals to manage wounds, burns, and ulcers. It also cleared for over-the-counter use on minor skin issues like lacerations and burns. The clearance follows more rigorous biocompatibility testing and applies to 50mL bottles with a 24-month shelf life.

November 11, 2024
6 Articles

Further Reading